SGD Pharma has launched the first App to identify non-compliances in moulded glass bottles intended for the pharmaceutical industry. Resulting from a development project between SGD Pharma Quality and Marketing Departments, this digital tool makes it possible to identify non-compliances that may be discovered during an incoming inspection or during on-line inspection at the client's side.

Available free from the Apple Store and the Play Store, it only takes a few clicks for users to create their account and have unlimited access to a 2D visual compilation of the most frequently encountered forms of non-compliance. Users can refine their searches by administration method (parenteral, oral or nasal), by location or non-compliance types corresponding to various effects on the patients or on filling lines (critical, major or cosmetic).

Once a non-compliance has been identified, the user accesses a dedicated page including a visual, a definition, the type of non-compliance and its associated acceptable quality level (AQL) in conjunction with the international standard ISO 2859-1. As an added benefit, the SGD Pharma standards are then cross-referenced with the two quality benchmarks recognised and accepted by the pharmaceutical industry: Technical report 43 from the Parenteral Drug Association (PDA) and the list of moulded glass container non-compliances from Edito-Cantor-Verlag (ECV).

www.sgd-pharma.com